Supply Chain/Technology

Latest Issue of OR Manager
September 2025
Home Supply Chain/Technology

FDA: Class I recall of Getinge Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems

Editor's Note The Food and Drug Administration (FDA) on January 19 identified the recall by Getinge of its Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems as Class I, the most serious. The recall was initiated because of the potential chemical breakdown of Sevoflurane that may result in inhalation…

Read More

By: Judy Mathias
January 20, 2022
Share

Integrated data, insights lead to cost, time savings for OR staff

In 2020, supply costs were once again reported as one of the greatest line-item expenses in a hospital, exceeding labor expenses. US hospitals have most recently reported a combined $36 billion in medical and surgical supply costs. These expenses account for more than half of a hospital’s total supply costs.…

Read More

By: Shawn McBride
January 20, 2022
Share

ECRI names Top 10 Health Technology Hazards for 2022

Editor's Note ECRI has named cybersecurity attacks as the number one health technology hazard for 2022. In its report, ECRI notes that all healthcare organizations are subject to cybersecurity attacks, and that the question is not whether they will be attacked but when. A cybersecurity attack could threaten medical devices…

Read More

By: Judy Mathias
January 19, 2022
Share

FDA: Class I recall of Medtronic Synergy Cranial, StealthStation S7 cranial software

Editor's Note The Food and Drug Administration (FDA) on January 6 identified the recall by Medtronic of its Stealth Station System with Synergy Cranial and StealthStation S7 Cranial Software as Class I, the most serious. The System aids in precisely locating anatomical structures in neurosurgical procedures. The recall was initiated…

Read More

By: Judy Mathias
January 18, 2022
Share

Sponsored Message

FDA: Class I recall of Cardiovascular Systems’ WIRION Embolic Protection Device

Editor's Note The Food and Drug Administration (FDA), on January 10, identified the recall of Cardiovascular Systems’ WIRION Embolic Protection Device as Class I, the most serious. The device, which is used to hold or remove debris or blood clots from the lower limbs, was recalled because of complaints of…

Read More

By: Judy Mathias
January 11, 2022
Share

FDA: Class I recall of Puritan Bennett 980 Series Ventilator

Editor's Note The Food and Drug Administration (FDA), on January 3, identified the recall by Covidien of its Puritan Bennett 980 Series Ventilator as Class I, the most serious. The recall was initiated because of a capacitor manufacturing assembly error that may cause the ventilator to become inoperable or stop…

Read More

By: Judy Mathias
January 5, 2022
Share

Sponsored Message

FDA: Class I recall of Getinge/Datascope/Maquet Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps

Editor's Note The Food and Drug Administration, on December 16, identified the recall by Getinge/Datascope/Maquet of its Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The IABPs are cardiac assist devices used in patients having cardiac and noncardiac surgery and to treat patients…

Read More

By: Judy Mathias
December 16, 2021
Share

Four problems and solutions with physician preference cards

As representatives of a global healthcare solutions company, we talk and listen to clinicians at hospitals around the country. One of the issues that continually surfaces is that physician preference cards (PPCs) are a challenge at their hospitals. We hear many frustrations related to supply chain documentation. In the end, it all comes…

Read More

By: Vicky Lyle
December 16, 2021
Share

FDA: Class I recall of Teleflex percutaneous thrombolytic device kit

Editor's Note The Food and Drug Administration (FDA), on November 30, identified the worldwide recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as Class I, the most serious. The device, which is used for mechanical declotting of native arteriovenous fistulae and synthetic dialysis grafts, was…

Read More

By: Judy Mathias
December 2, 2021
Share

FDA: Nationwide recall of certain SterRx drug products

Editor's Note The Food and Drug Administration (FDA), on November 15, announced the nationwide recall by SterRx, LLC, of 240 lots of its drug products. The recall was initiated because of the lack of sterility assurance due to equipment and process issues. The recalled drugs include: l mg/ml Midazolam in…

Read More

By: Judy Mathias
November 18, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat